Cargando…

Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice

OBJECTIVES: Prior studies noted that chondrocyte SIRT6 activity is repressed in older chondrocytes rendering cells susceptible to catabolic signalling events implicated in osteoarthritis (OA). This study aimed to define the effect of Sirt6 deficiency on the development of post-traumatic and age-asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, John A, Kim, C James, Coleman, Ashley, Little, Abreah, Perez, Matheus M, Clarke, Emily J, Diekman, Brian, Peffers, Mandy J, Chubinskaya, Susanna, Tomlinson, Ryan E, Freeman, Theresa A, Loeser, Richard F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579179/
https://www.ncbi.nlm.nih.gov/pubmed/37550003
http://dx.doi.org/10.1136/ard-2023-224385
_version_ 1785121669556207616
author Collins, John A
Kim, C James
Coleman, Ashley
Little, Abreah
Perez, Matheus M
Clarke, Emily J
Diekman, Brian
Peffers, Mandy J
Chubinskaya, Susanna
Tomlinson, Ryan E
Freeman, Theresa A
Loeser, Richard F
author_facet Collins, John A
Kim, C James
Coleman, Ashley
Little, Abreah
Perez, Matheus M
Clarke, Emily J
Diekman, Brian
Peffers, Mandy J
Chubinskaya, Susanna
Tomlinson, Ryan E
Freeman, Theresa A
Loeser, Richard F
author_sort Collins, John A
collection PubMed
description OBJECTIVES: Prior studies noted that chondrocyte SIRT6 activity is repressed in older chondrocytes rendering cells susceptible to catabolic signalling events implicated in osteoarthritis (OA). This study aimed to define the effect of Sirt6 deficiency on the development of post-traumatic and age-associated OA in mice. METHODS: Male cartilage-specific Sirt6-deficient mice and Sirt6 intact controls underwent destabilisation of the medial meniscus (DMM) or sham surgery at 16 weeks of age and OA severity was analysed at 6 and 10 weeks postsurgery. Age-associated OA was assessed in mice aged 12 and 18 months of age. OA severity was analysed by micro-CT, histomorphometry and scoring of articular cartilage structure, toluidine blue staining and osteophyte formation. SIRT6-regulated pathways were analysed in human chondrocytes by RNA-sequencing, qRT-PCR and immunoblotting. RESULTS: Sirt6-deficient mice displayed enhanced DMM-induced OA severity and accelerated age-associated OA when compared with controls, characterised by increased cartilage damage, osteophyte formation and subchondral bone sclerosis. In chondrocytes, RNA-sequencing revealed that SIRT6 depletion significantly repressed cartilage extracellular matrix (eg, COL2A1) and anabolic growth factor (eg, insulin-like growth factor-1 (IGF-1)) gene expression. Gain-of-function and loss-of-function studies in chondrocytes demonstrated that SIRT6 depletion attenuated, whereas adenoviral overexpression or MDL-800-induced SIRT6 activation promoted IGF-1 signalling by increasing Akt(ser473) phosphorylation. CONCLUSIONS: SIRT6 deficiency increases post-traumatic and age-associated OA severity in vivo. SIRT6 profoundly regulated the pro-anabolic and pro-survival IGF-1/Akt signalling pathway and suggests that preserving the SIRT6/IGF-1/Akt axis may be necessary to protect cartilage from injury-associated or age-associated OA. Targeted therapies aimed at increasing SIRT6 function could represent a novel strategy to slow or stop OA.
format Online
Article
Text
id pubmed-10579179
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-105791792023-10-18 Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice Collins, John A Kim, C James Coleman, Ashley Little, Abreah Perez, Matheus M Clarke, Emily J Diekman, Brian Peffers, Mandy J Chubinskaya, Susanna Tomlinson, Ryan E Freeman, Theresa A Loeser, Richard F Ann Rheum Dis Osteoarthritis OBJECTIVES: Prior studies noted that chondrocyte SIRT6 activity is repressed in older chondrocytes rendering cells susceptible to catabolic signalling events implicated in osteoarthritis (OA). This study aimed to define the effect of Sirt6 deficiency on the development of post-traumatic and age-associated OA in mice. METHODS: Male cartilage-specific Sirt6-deficient mice and Sirt6 intact controls underwent destabilisation of the medial meniscus (DMM) or sham surgery at 16 weeks of age and OA severity was analysed at 6 and 10 weeks postsurgery. Age-associated OA was assessed in mice aged 12 and 18 months of age. OA severity was analysed by micro-CT, histomorphometry and scoring of articular cartilage structure, toluidine blue staining and osteophyte formation. SIRT6-regulated pathways were analysed in human chondrocytes by RNA-sequencing, qRT-PCR and immunoblotting. RESULTS: Sirt6-deficient mice displayed enhanced DMM-induced OA severity and accelerated age-associated OA when compared with controls, characterised by increased cartilage damage, osteophyte formation and subchondral bone sclerosis. In chondrocytes, RNA-sequencing revealed that SIRT6 depletion significantly repressed cartilage extracellular matrix (eg, COL2A1) and anabolic growth factor (eg, insulin-like growth factor-1 (IGF-1)) gene expression. Gain-of-function and loss-of-function studies in chondrocytes demonstrated that SIRT6 depletion attenuated, whereas adenoviral overexpression or MDL-800-induced SIRT6 activation promoted IGF-1 signalling by increasing Akt(ser473) phosphorylation. CONCLUSIONS: SIRT6 deficiency increases post-traumatic and age-associated OA severity in vivo. SIRT6 profoundly regulated the pro-anabolic and pro-survival IGF-1/Akt signalling pathway and suggests that preserving the SIRT6/IGF-1/Akt axis may be necessary to protect cartilage from injury-associated or age-associated OA. Targeted therapies aimed at increasing SIRT6 function could represent a novel strategy to slow or stop OA. BMJ Publishing Group 2023-11 2023-08-07 /pmc/articles/PMC10579179/ /pubmed/37550003 http://dx.doi.org/10.1136/ard-2023-224385 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Osteoarthritis
Collins, John A
Kim, C James
Coleman, Ashley
Little, Abreah
Perez, Matheus M
Clarke, Emily J
Diekman, Brian
Peffers, Mandy J
Chubinskaya, Susanna
Tomlinson, Ryan E
Freeman, Theresa A
Loeser, Richard F
Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice
title Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice
title_full Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice
title_fullStr Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice
title_full_unstemmed Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice
title_short Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice
title_sort cartilage-specific sirt6 deficiency represses igf-1 and enhances osteoarthritis severity in mice
topic Osteoarthritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579179/
https://www.ncbi.nlm.nih.gov/pubmed/37550003
http://dx.doi.org/10.1136/ard-2023-224385
work_keys_str_mv AT collinsjohna cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT kimcjames cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT colemanashley cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT littleabreah cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT perezmatheusm cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT clarkeemilyj cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT diekmanbrian cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT peffersmandyj cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT chubinskayasusanna cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT tomlinsonryane cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT freemantheresaa cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice
AT loeserrichardf cartilagespecificsirt6deficiencyrepressesigf1andenhancesosteoarthritisseverityinmice